ArticlePsychogeriatrics : the official journal of the Japanese Psychogeriatric Society2026

Eligibility for Anti-Amyloid-β Monoclonal Antibodies in Patients With Primary Progressive Aphasia due to Alzheimer's Disease in Japan.

Shoya Inagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.